5-aminolevulinic acid fluorescence-guided resection of intramedullary ependymoma: Report of 9 cases

Neurosurgery

Volumn 72, Issue , 2013, Pages

  Inoue, Tomoo ^a   Endo, Toshiki ^a   Nagamatsu, Kenichi ^a   Watanabe, Mika ^a   Tominaga, Teiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Aminolevulinic acid; Electrophysiological monitoring; Intramedullary ependymoma; Photodynamic diagnosis; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; EPENDYMOMA; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; INTRAMEDULLARY EPENDYMOMA; MALE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPINAL CORD;

ADULT; AMINOLEVULINIC ACID; EPENDYMOMA; FEMALE; FLUORESCENT DYES; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; SPINAL CORD NEOPLASMS;

EID: 84879695323     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31827bc7a3     Document Type: Article

References (44)

1. Wo1un-Cholewa M, Szymanowski K, Nowak-Markwitz E, Warcho1 W. Photodiagnosis and photodynamic therapy of endometriotic epithelial cells using 5-aminolevulinic acid and steroids. Photodiagnosis Photodyn Ther. 2011;8(1):58-63.
2. Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 2010;116(6):1545-1552.
3. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescenceguided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6): 1003-1013.
4. Sherman JH, Hoes K, Marcus J, Komotar RJ, Brennan CW, Gutin PH. Neurosurgery for brain tumors: update on recent technical advances. Curr Neurol Neurosci Rep. 2011;11(3):313-319.
5. Stummer W, Tonn JC, Mehdorn HM, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study: clinical article. J Neurosurg. 2011;114(3):613-623.
6. Stummer W, Stepp H, Möller G, Ehrhardt A, Leonhard M, Reulen HJ. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien). 1998;140(10):995-1000.
7. Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998;42(3):518-525.
8. Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescenceguided resection of recurrent malignant gliomas: a phase II study. Neurosurgery. 2009;65(6):1070-1077.
9. Ewelt C, Stummer W, Klink B, Felsberg J, Steiger HJ, Sabel M. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg. 2010;112(4):357-361.
10. Blake E, Curnow A. The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells. Photochem Photobiol. 2010;86 (5):1154-1160.
11. Valdés PA, Samkoe K, O'Hara JA, Roberts DW, Paulsen KD, Pogue BW. Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model. Photochem Photobiol. 2010;86(2):471-475.
12. Haj-Hosseini N, Richter J, Andersson-Engels S, Wårdell K. Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. 2010;42(1):9-14.
13. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7 (5):392-401.
14. Shimizu S, Utsuki S, Sato K, Oka H, Fujii K, Mii K. Photodynamic diagnosis in surgery for spinal ependymoma: case illustration. J Neurosurg Spine. 2006;5(4):380.
15. McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72(4):523-532.
16. Aghakhani N, David P, Parker F, Lacroix C, Benoudiba F, Tadie M. Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit. Neurosurgery. 2008;62(6):1279-1285.
17. Miyazawa N, Hida K, Iwasaki Y, Koyanagi I, Abe H.MRI at 1.5 T of intramedullary ependymoma and classification of pattern of contrast enhancement. Neuroradiology. 2000;42(11):828-832.
18. Kahan H, Sklar EM, Post MJ, Bruce JH. MR characteristics of histopathologic subtypes of spinal ependymoma. AJNR Am J Neuroradiol. 1996;17(1):143-150.
19. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
20. Parsa AT, Chi JH, Acosta FL Jr, Ames CP, McCormick PC. Intramedullary spinal cord tumors: molecular insights and surgical innovation. Clin Neurosurg. 2005;52: 76-84.
21. Sun B, Wang C, Wang J, Liu A. MRI features of intramedullary spinal cord ependymomas. J Neuroimaging. 2003;13(4):346-351.
22. Chamberlain MC. Salvage chemotherapy for recurrent spinal cord ependymona. Cancer. 2002;95(5):997-1002.
23. Chamberlain MC, Tredway TL. Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep. 2011;11(3):320-328.
24. Chang UK, Choe WJ, Chung SK, Chung CK, Kim HJ. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neurooncol. 2002;57(2):133-139.
25. Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg. 1993;79(2):204-209.
26. Lin YH, Huang CI, Wong TT, et al. Treatment of spinal cord ependymomas by surgery with or without postoperative radiotherapy. J Neurooncol. 2005;71(2):205-210.
27. Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, part 1: intramedullary ependymomas. Neurosurgery. 2011;68(1 suppl operative):57-63.
28. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg. 2000;93 (2 suppl):183-193.
29. Nakamura M, Ishii K,Watanabe K, et al. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord. 2008;46(4):282-286.
30. Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long-term followup of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery. 2005; 56(5):972-981; discussion 972-981.
31. Nagasawa DT, Smith ZA, Cremer N, Fong C, Lu DC, Yang I. Complications associated with the treatment for spinal ependymomas. Neurosurg Focus. 2011;31 (4):E13.
32. Halvorsen CM, Kolstad F, Hald J, et al. Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery. 2010;67 (6):1622-1631.
33. Brotchi J. Intrinsic spinal cord tumor resection. Neurosurgery. 2002;50(5):1059-1063.
34. Brotchi J, Bruneau M, Lefranc F, Balériaux D. Surgery of intraspinal cord tumors. Clin Neurosurg. 2006;53:209-216.
35. Brotchi J, Fischer G. Spinal cord ependymomas. Neurosurg Focus. 1998;4(5):e2.
36. Kothbauer K, Deletis V, Epstein FJ. Intraoperative spinal cord monitoring for intramedullary surgery: an essential adjunct. Pediatr Neurosurg. 1997;26(5):247-254.
37. Kothbauer KF, Deletis V, Epstein FJ. Motor-evoked potential monitoring for intramedullary spinal cord tumor surgery: correlation of clinical and neurophysiological data in a series of 100 consecutive procedures. Neurosurg Focus. 1998;4(5):e1.
38. Cooper PR. Outcome after operative treatment of intramedullary spinal cord tumors in adults: intermediate and long-term results in 51 patients. Neurosurgery. 1989;25(6):855-859.
39. Matsuyama Y, Sakai Y, Katayama Y, et al. Surgical results of intramedullary spinal cord tumor with spinal cord monitoring to guide extent of resection. J Neurosurg Spine. 2009;10(5):404-413.
40. Samii M, Klekamp J. Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery. 1994;35(5):865-873.
41. Grabb PA, Gilbert MR. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. J Neurosurg. 1995;82(6):1053-1058.
42. Cowled PA, Mackenzie L, Forbes IJ. Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids. Cancer Lett. 1985;29(1):107-114.
43. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo). 2007;47(2):53-57; discussion 57.
44. Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP. Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys. 2009;73(3): 727-733.